Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A

NCT05281185 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Severe Hemophilia A Without Inhibitor

Interventions

DRUG: Extended half-life FVIII concentrates with PK-guided dosing
DRUG: standard half-life FVIII concentrates with weight-based dosing

Sponsor

Chulalongkorn University